Cybin Completes $34.5 Million Overnight Marketed Offering
On August 3, 2021, Cybin Inc. (NEO: CYBN) (the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, completed an overnight marketed offering pursuant to a prospectus supplement to the Company’s short form base shelf prospectus dated July 5, 2021. In connection with the offering, the Company issued 10,147,600 common shares at a price of $3.40 per common share for aggregate gross proceeds of $34,501,840.
Cybin intends to use the net proceeds from the offering for general corporate and working capital purposes.
Aird & Berlis acted for Cybin with a team that included Sherri Altshuler, Marek Lorenc, Danny Kharazmi, Sean Green and Meredith McCann (Capital Markets/M&A) and Barbara Worndl (Tax).
-
BioFull bio
Sherri earns the trust of her clients by adeptly managing complex and time-sensitive corporate finance transactions and by providing relevant, busines...
-
BioFull bio
Marek is a creative, pragmatic, and business-focused lawyer.
-
BioFull bio
Danny thrives on finding effective and creative solutions to help clients navigate through highly-regulated industries.
-
BioFull bio
When it comes to complex capital markets transactions, Sean provides clients with the support they need to navigate corporate laws and achieve their b...
-
BioFull bio
When it comes to complex capital markets transactions or navigating regulatory requirements, Meredith’s primary focus is on her clients’ i...
-
BioFull bio
Clients appreciate Barbara’s dedication to finding the most tax efficient structures for their business. She thrives on the complexities of tax ...
